TY - CHAP
T1 - Illegal Stimulants Use in Brazil
T2 - Epidemiological Aspects and Possible Reasons for High Consumption of Crack/Cocaine and Amphetamine-type Stimulants
AU - Abdalla, Renata Rigacci
AU - Caetano, Raul
AU - Massaro, Luciana
AU - Mitsuhiro, Sandro
AU - Pinsky, Ilana
AU - Laranjeira, Ronaldo Ramos
AU - Madruga, Clarice Sandi
N1 - Publisher Copyright:
© 2016 Elsevier Inc. All rights reserved.
Copyright:
Copyright 2016 Elsevier B.V., All rights reserved.
PY - 2016/4/15
Y1 - 2016/4/15
N2 - The trend of stimulant use, especially crack cocaine, carries worrisome ramifications in Brazil, whose population of 200. million includes a young, booming, new middle class, as well as a large, economically disadvantaged and uneducated tier of society; both are equally vulnerable to drug abuse and addiction. The geographically continental-sized proportions of Brazil impose a challenge when performing nationally representative surveys. Nevertheless, the Brazilian Alcohol and Drugs Survey (BNADS), carried out in 2012, overcame this barrier and estimated consumption prevalence rates of the main psychoactive substances in the country. The results highlight that indeed Brazil is among the nations with notably high consumption rates of crack cocaine and amphetamine-type stimulants (ATS), with nearly 2% and 1.6% of its population (aged 14. years and older) having used drugs in the past year. The prevalence of cocaine addiction in the population was estimated at 0.6% according to the Severity of Dependence Scale (SDS). Predictors of consumption differed among the substances studied: although men were nearly 4 times more likely to use cocaine compared to women, the risk of ATS use was higher for women. Socioeconomic status affected only ATS consumption, where the risk increased among the economically privileged. Finally it is imperative to point out that the sheer estimated number of users makes Brazil one of the greatest worldwide consumer markets for stimulants; yet the nation is still not taking the necessary actions to expand and generate solid frameworks for addiction-specific health care, let alone the implementation of prevention interventions.
AB - The trend of stimulant use, especially crack cocaine, carries worrisome ramifications in Brazil, whose population of 200. million includes a young, booming, new middle class, as well as a large, economically disadvantaged and uneducated tier of society; both are equally vulnerable to drug abuse and addiction. The geographically continental-sized proportions of Brazil impose a challenge when performing nationally representative surveys. Nevertheless, the Brazilian Alcohol and Drugs Survey (BNADS), carried out in 2012, overcame this barrier and estimated consumption prevalence rates of the main psychoactive substances in the country. The results highlight that indeed Brazil is among the nations with notably high consumption rates of crack cocaine and amphetamine-type stimulants (ATS), with nearly 2% and 1.6% of its population (aged 14. years and older) having used drugs in the past year. The prevalence of cocaine addiction in the population was estimated at 0.6% according to the Severity of Dependence Scale (SDS). Predictors of consumption differed among the substances studied: although men were nearly 4 times more likely to use cocaine compared to women, the risk of ATS use was higher for women. Socioeconomic status affected only ATS consumption, where the risk increased among the economically privileged. Finally it is imperative to point out that the sheer estimated number of users makes Brazil one of the greatest worldwide consumer markets for stimulants; yet the nation is still not taking the necessary actions to expand and generate solid frameworks for addiction-specific health care, let alone the implementation of prevention interventions.
KW - Addiction
KW - Amphetamine type stimulants (ATS)
KW - Brazil
KW - Crack cocaine
KW - National survey
KW - Stimulants
UR - http://www.scopus.com/inward/record.url?scp=84969641415&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84969641415&partnerID=8YFLogxK
U2 - 10.1016/B978-0-12-800212-4.00100-X
DO - 10.1016/B978-0-12-800212-4.00100-X
M3 - Chapter
AN - SCOPUS:84969641415
SN - 9780128002124
VL - 2
SP - 1085
EP - 1093
BT - Stimulants, Club and Dissociative Drugs, Hallucinogens, Steroids, Inhalants and International Aspects
PB - Elsevier Inc.
ER -